Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obesity and Diabetes Therapy
Researchers from Catholic University publish new studies and findings in the area of obesity and diabetes therapy
December 10th, 2007
New research, 'The obese older female patient: CV risk and the SCOUT study,' is the subject of a report. According to recent research published in the International Journal of Obesity, "Cardiovascular disease is a major killer in women yet is frequently considered a male-dominated disease. The risk of cardiovascular disease in women is frequently underestimated and there is also considerable evidence of a treatment bias against women." "Women are generally underrepresented in cardiovascular clinical trials yet there is evidence of gender-specific differences in the responses to pharmacotherapy. The Sibutramine Cardiovascular Outcomes (SCOUT) trial has been...
Source: Obesity & Diabetes Week (2007-12-10)
|
